Literature DB >> 29460192

Aberrant Expression of Some Circulating miRNAs in Childhood Acute Lymphoblastic Leukemia.

Menha Swellam1,2, Maha Hashim3,4, Magda Sayed Mahmoud3,4, Amal Ramadan3,4, Naglaa M Hassan5.   

Abstract

Acute lymphoblastic leukemia (ALL) is a heterogeneous cancer commonly affecting children due to dysregulation of miRNA expression. In the current study, authors investigated the expression profile for miRNA-125b-1 and miRNA-203 among childhood ALL. Blood samples were collected from newly diagnosed childhood ALL and healthy control children. The expression profile for candidate miRNAs was detected using quantitative RT-PCR analysis. Statistical analysis were performed using receiver operating characteristic curve (ROC) to examine the diagnostic efficacy of the two miRNA and their levels among ALL clinicopathological factors and phenotypes. The median expression level for miRNA-125b-1 was significantly high in childhood ALL; while miRNA-203 level was significantly low in childhood ALL as compared to control ones. MiRNA-125-1 reported significant increase in T-ALL as compared to other ALL phenotypes. Median miRNA-203 level was high in T-ALL followed by pre-B-ALL although no significant difference was reported. Clinicopathological factors did not emphasize significance with either detected miRNAs. Using ROC curve the diagnostic efficacy was significant with an area under the curve 0.858 for miRNA-125b-1 (83.72, 100%) and 0.878 for miRNA-203 (97.67, 86.96%). The combination of the two key miRNAs revealed absolute sensitivity (100%). MiRNA-125b-1 and miRNA-203 can be useful molecular markers for diagnosis of ALL. Further studies with large cohort are warranted to validate these results.

Entities:  

Keywords:  ALL; Circulating molecular marker; Diagnosis; MiRNAs

Mesh:

Substances:

Year:  2018        PMID: 29460192     DOI: 10.1007/s10528-018-9844-y

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  11 in total

1.  The Role of MiRNA in Cancer: Pathogenesis, Diagnosis, and Treatment.

Authors:  Erez Uzuner; Gizem Tugçe Ulu; Sevim Beyza Gürler; Yusuf Baran
Journal:  Methods Mol Biol       Date:  2022

2.  MicroRNA expression is deregulated by aberrant methylation in B-cell acute lymphoblastic leukemia mouse model.

Authors:  Wei Xia; Limei Liu; Yidan Wang; Yihan Wang; Hetong Hui; Xinyuan Fan; Tianqi Wang
Journal:  Mol Biol Rep       Date:  2022-01-10       Impact factor: 2.316

Review 3.  The power of microRNAs as diagnostic and prognostic biomarkers in liquid biopsies.

Authors:  Lorena Quirico; Francesca Orso
Journal:  Cancer Drug Resist       Date:  2020-02-21

4.  Emerging role of miRNAs as liquid biopsy markers for prediction of glioblastoma multiforme prognosis.

Authors:  Menha Swellam; Noha M Bakr; Hekmat M El Magdoub; Marwa S Hamza; Lobna R Ezz El Arab
Journal:  J Mol Neurosci       Date:  2020-09-28       Impact factor: 3.444

5.  Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia.

Authors:  Andrea Rzepiel; Nóra Kutszegi; András Gézsi; Judit C Sági; Bálint Egyed; György Péter; Henriett Butz; Gábor Nyírő; Judit Müller; Gábor T Kovács; Csaba Szalai; Ágnes F Semsei; Dániel J Erdélyi
Journal:  J Transl Med       Date:  2019-11-14       Impact factor: 5.531

Review 6.  The Role of MicroRNA in Paediatric Acute Lymphoblastic Leukaemia: Challenges for Diagnosis and Therapy.

Authors:  Carle Grobbelaar; Anthony M Ford
Journal:  J Oncol       Date:  2019-10-13       Impact factor: 4.375

7.  The Potential Diagnostic Accuracy of Circulating MicroRNAs for Leukemia: A Meta-Analysis.

Authors:  Wen-Ting Zhang; Guo-Xun Zhang; Shuai-Shuai Gao
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

Review 8.  Small Non-Coding RNAs in Leukemia.

Authors:  Veronica Balatti; Carlo M Croce
Journal:  Cancers (Basel)       Date:  2022-01-20       Impact factor: 6.639

Review 9.  MiRNA Dysregulation in Childhood Hematological Cancer.

Authors:  Jaqueline Carvalho de Oliveira; Gabriela Molinari Roberto; Mirella Baroni; Karina Bezerra Salomão; Julia Alejandra Pezuk; María Sol Brassesco
Journal:  Int J Mol Sci       Date:  2018-09-10       Impact factor: 5.923

Review 10.  Overview of current microRNA biomarker signatures as potential diagnostic tools for leukaemic conditions.

Authors:  Alfred Buhagiar; Joseph Borg; Duncan Ayers
Journal:  Noncoding RNA Res       Date:  2020-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.